cord blood-derived CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-012771
A preparation of umbilical cord blood (CB)-derived T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of the cord blood derived CAR T cells, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.
| Identifier | MLC-T-ONC-012771 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CB-derived CAR T cells; cord blood CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012771",
"term": "cord blood-derived CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of umbilical cord blood (CB)-derived T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of the cord blood derived CAR T cells, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.",
"synonyms": [
"CB-derived CAR T cells",
"cord blood CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cord-blood-derived-car-t-cells/"
}
Record 5,324 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.